Status:
COMPLETED
Open Label Trial of Perifosine in Patients Currently Being Treated on Perifosine Trials in Solid Tumors or Multiple Myeloma
Lead Sponsor:
AEterna Zentaris
Conditions:
Non Small Cell Lung Cancer
Solid Tumors
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This is an open label trial for patients currently enrolled in other perifosine trials.
Detailed Description
Perifosine is an oral anticancer agent with limited toxicity and a novel mechanism of action that is distinctly different from cytotoxic chemotherapies. It has been shown to inhibit and otherwise modi...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Patients must be currently receiving treatment with perifosine on a previously approved protocol.
- Patients must have had at least one evaluation following the initiation of treatment and have stable disease, partial response or complete response.
- Patient is willing to sign a new consent Regarding the protocol no exclusion criteria are described.
Exclusion
Key Trial Info
Start Date :
May 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2012
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT00847366
Start Date
May 1 2008
End Date
December 1 2012
Last Update
March 15 2018
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.